NR
NurExone Biologic Inc.
NRXBF · OTC
$0.49 +2.61% (+$0.01)
1M +12.10%
Valuation
-
N/A P/E N/A
EV/FFO N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
-
N/A ROIC N/A
Asset turnover N/A
ROE N/A
Debt
-
N/A Debt/Equity N/A
Debt/Assets N/A
Current ratio N/A
Stability
47 /100
Moderate Beta 0.39x
Rev. volatility N/A
Profitable years N/A
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NRXBF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Lior Shaltiel
Employees
16
Headquarters
Toronto
Prihajajoči dogodki
25 NOV.
Earnings
Upcoming earnings report